Page last updated: 2024-11-08

kojibiose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID4390805
MeSH IDM0051925

Synonyms (11)

Synonym
LS-14146
kojibiose
3,4,5,6-tetrahydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal
FT-0637996
FT-0613239
FT-0634058
kojibiose, >=98% (hplc)
2-o-(b-d-galactopyranosyl)-d-glucose
28447-37-2
|a-sophorose
2-o-(a-d-glucopyranosyl)-d-galactose
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (27.50)18.7374
1990's5 (12.50)18.2507
2000's6 (15.00)29.6817
2010's14 (35.00)24.3611
2020's4 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]